Omniasecure, which was authorized for placement in the heart’s right ventricle, is the world’s smallest defibrillation lead, ...

The US Food and Drug Administration (FDA) has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for ...

Medtronic (NYSE: MDT) announced that it received FDA approval for its OmniaSecure defibrillation lead for right ventricle ...

Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for the OmniaSecure defibrillation lead for ...

Medtronic receives US FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure lead: Galway, ...

Medtronic said its OmniaSecure device can be used to treat potentially life-threatening conditions including ventricular tachyarrhythmias, a heart rhythm disorder where the heart's lower chambers beat ...

Adding to the Medtronic portfolio of catheter-based lead solutions, the novel OmniaSecure defibrillation lead allows for precise delivery and placement in the right ventricle Heart Rhythm 2025 ...

A system hybridizing cardiac contractility modulation and implantable cardioverter defibrillation successfully converted ...

Two members of the Wyoming Air National Guard played critical roles in the first successful evacuation of a patient in ...

Medtronic received approval for its OmniaSecure defibrillation lead for placement within the right ventricle, from the Food and Drug Administration. The medical technology company said Friday that ...